Vitamin D, Breast Cancer and Bone Health
Abstract
This is a multidisciplinary postdoctoral award investigating the role of vitamin D in aromatase inhibitor-induced osteoporosis in breast cancer, supporting studies in basic science, clinical research and epidemiology. During the reporting period, the recipient successfully made the transition towards becoming an independent investigator in translational research the breast cancer field. After several cycles of optimizing and re-designing the protocol, the clinical trial received all necessary approvals including the IND from the FDA, and approvals from the IRB's from both at Stanford University and the DoD, and recruitment is expected to start shortly. The recipient completed the majority of core courses and requirements for the Master's degree in Epidemiology, and is currently working on the master's thesis on the role of vitamin D in breast cancer in general, with a special focus on aromatase inhibitor-induced bone loss. For the animal studies, the recipient obtained all necessary approvals for the experiments (Stanford University and DoD), and the studies will be performed during the second year.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2008
- Accession Number
- ADA499634
Entities
People
- Eva Balint
Organizations
- Stanford University